Metraipolis › archive › dc_8c4e98315aed

Comparative Long-Term Cardiovascular Outcomes of Empagliflozin and Dapagliflozin in Heart Failure Patients After Coronary Revascularization: A Retrospective… — Europe PMC PMID:41375685

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41375685
DOI
10.3390/jcm14238383
License (as archived)
solo-consultazione
Archived
2026-11-08T05:50:39.647Z
SHA-256 of the archived text
e73c78602f44dbc5fc81f99eed6b95b8d8eac7462947c06f0fc491cc2d3227b9
Stable URL of this page
https://metraipolis.com/documento/dc_8c4e98315aed

How to cite

Comparative Long-Term Cardiovascular Outcomes of Empagliflozin and Dapagliflozin in Heart Failure Patients After Coronary Revascularization: A Retrospective… — Europe PMC PMID:41375685 — Europe PMC (en), https://europepmc.org/article/MED/41375685 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8c4e98315aed (Metraipolis archive dc_8c4e98315aed, sha256 e73c78602f44dbc5fc81f99eed6b95b8d8eac7462947c06f0fc491cc2d3227b9)
BibTeX
@misc{dc8c4e98315aed,
  title = {Comparative Long-Term Cardiovascular Outcomes of Empagliflozin and Dapagliflozin in Heart Failure Patients After Coronary Revascularization: A Retrospective… — Europe PMC PMID:41375685},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41375685},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8c4e98315aed; sha256 e73c78602f44dbc5fc81f99eed6b95b8d8eac7462947c06f0fc491cc2d3227b9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41375685. Agents can read the archived copy with the MCP tool read_document.